A Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques

Document Type : Short communication


1 Department of Radiology, Perelman School of Medicine, University of Pennsylvania, PA, United States

2 Department of Medicine, Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA, United States


Objective(s): Functional imaging presents a non-invasive process that may capture the hyper-metabolic nature of red bone marrow in myeloproliferative neoplasms, such as polycythemia vera (PV).
Methods: This study analyzed the FDG-PET/CT scans (n=12) of six patients diagnosed with PV and six age-sex matched controls using a quantitative global analysis methodology.
Results: All PV patients had elevated activities in the bone marrow of each skeletal structure as compared to matched controls with respect to mean standardized uptake value (femoral neck p=0.01, lumbar spine p=0.02, pelvis p=0.002, sternum p=0.04). Notable variations in splenic uptake were observed among the treated and untreated PV patients.  
Conclusion: Our study exemplifies the potential utility of PET in reflecting hyperactive bone marrow activity related to PV. Future studies may further substantiate and elaborate on the use of PET-derived metabolic data in PV.


Main Subjects

1. Jakovic L, Gotic M, Gisslinger H, Soldatovic I, Sefer D, Tirnanic M, Lekovic D, et al. The WHO diagnostic criteria for polycythemia vera— role of red cell mass versus hemoglobin/hematocrit level and morphology. Annals of Hematology. 2018; 97(9):1581-1590.
2. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. American Journal of Hematology. 2015; 90(2):162-173.
3. Agool A, Glaudemans AWJM, Boersma HH, Dierckx RAJO, Vellenga E, Slart RHJA. Radionuclide imaging of bone marrow disorders. European Journal of Nuclear Medicine and Molecular Imaging.2010; 38(1):166-178.
4. Basu S, Asopa R, Peshwe H, Mohandas KM. Diffuse Intense FDG Uptake in the Bone Marrow in Gastrointestinal Stromal Tumor with Coexistent Polycythemia Rubra Vera. Clinical Nuclear Medicine.2008; 33(11):782-783.
5. Van Ufford H, Jong JAFD, Baarslag HJ, Haas MJD, Oud K, Klerk JMHD. F-18 FDG PET in a Patient With Polycythemia Vera. Clinical Nuclear Medicine.2008; 33(11):780-781.
6. Fujimi A, Kanisawa Y, Minami S, Kamihara Y, Iwasaki S. Focal 18F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm. International Journal of Hematology. 2013; 99(1):1-3.
7. Ayubcha C, Zirakchian Zadeh M, Stochkendahl MJ, Al-Zaghal A, Hartvigsen J, Rajapakse CS, et al. Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET/CT. Nuclear Medicine Communications. 2018.39(10):945-950.
8. Ayubcha C, Zadeh MZ, Rajapakse CS, Hartvigsen J, Stochkendahl MJ, Raynor W, et al. Effects of age and weight on the metabolic activities of the cervical, thoracic and lumbar spines as measured by fluorine-18 fluorodeoxyglucose-positron emission tomography in healthy males. Hellenic Journal of Nuclear Medicine. 2018; 39(10):945-950.
9. Yarbro JW. Mechanism of action of hydroxyurea. Seminars in oncology. 1992; 19:1-10.
10. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of Lean Bodyweight. Clinical Pharmacokinetics. 2005; 44 (10):1051-1065.
11. Bain BJ. Bone marrow biopsy morbidity and mortality. British Journal of Haematology. 2003; 121(6):949-951.
12. Sadıç M, Houshmand S, Alavi A. Quantitative Global Disease Assessment of FDG-PET/CT Yeni Bir Teknik: FDG-PET/CT ile Quantitative Global Hastalık Degerlendirme. Journal of Clinical Analytical Medicine. 2015; 6(3):-doi: 10.4328/ 54.